These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11848149)

  • 1. The cost-effectiveness of residential radon remediation programmes: assumptions about benefits stream profiles over time.
    Kennedy CA; Gray AM; Denman AR; Phillips PS
    J Environ Radioact; 2002; 59(1):19-28. PubMed ID: 11848149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new methodology for cost-effectiveness studies of domestic radon remediation programmes: quality-adjusted life-years gained within primary care trusts in central England.
    Coskeran T; Denman A; Phillips P; Gillmore G; Tornberg R
    Sci Total Environ; 2006 Jul; 366(1):32-46. PubMed ID: 16574198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effectiveness analysis of a residential radon remediation programme in the United Kingdom.
    Kennedy CA; Gray AM; Denman AR; Phillips PS
    Br J Cancer; 1999 Dec; 81(7):1243-7. PubMed ID: 10584889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness analysis of radon remediation programmes.
    Kennedy CA; Gray AM
    Sci Total Environ; 2001 May; 272(1-3):9-15. PubMed ID: 11379943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future initiatives to reduce lung cancer incidence in the United Kingdom: smoking cessation, radon remediation and the impact of social change.
    Denman AR; Rogers S; Timson K; Phillips PS; Crockett RG; Groves-Kirkby CJ
    Perspect Public Health; 2015 Mar; 135(2):92-101. PubMed ID: 24607815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost effectiveness of radon mitigation in existing German dwellings--a decision theoretic analysis.
    Haucke F
    J Environ Manage; 2010 Nov; 91(11):2263-74. PubMed ID: 20619957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them.
    Gray A; Read S; McGale P; Darby S
    BMJ; 2009 Jan; 338():a3110. PubMed ID: 19129153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs of radon mitigation in domestic properties.
    Coskeran T; Denman A; Phillips P
    Health Policy; 2001 Aug; 57(2):97-109. PubMed ID: 11395177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revealed preference valuation compared to contingent valuation: radon-induced lung cancer prevention.
    Kennedy CA
    Health Econ; 2002 Oct; 11(7):585-98. PubMed ID: 12369061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering the UK domestic radon Action Level to prevent more lung cancers--is it cost-effective?
    Denman AR; Coskeran T; Phillips PS; Crockett RG; Tornberg R; Groves-Kirkby CJ
    J Radiol Prot; 2008 Mar; 28(1):61-71. PubMed ID: 18309195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The costs and benefits of radon remediation programmes in existing homes: case study of action level selection.
    Denman AR; Phillips PS; Tornberg R
    J Environ Radioact; 2002; 62(1):17-27. PubMed ID: 12141604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness analysis of lowering residential radon levels in Sweden-Results from a modelling study.
    Svensson M; Barregård L; Axelsson G; Andersson E
    Health Policy; 2018 Jun; 122(6):687-692. PubMed ID: 29576334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined analysis of North American case-control studies of residential radon and lung cancer.
    Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Field RW; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
    J Toxicol Environ Health A; 2006 Apr; 69(7):533-97. PubMed ID: 16608828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radon and lung cancer: a cost-effectiveness analysis.
    Ford ES; Kelly AE; Teutsch SM; Thacker SB; Garbe PL
    Am J Public Health; 1999 Mar; 89(3):351-7. PubMed ID: 10076484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the individual health benefits accruing from a domestic radon remediation programme.
    Denman AR; Phillips PS; Tornberg R; Groves-Kirkby CJ
    J Environ Radioact; 2005; 79(1):7-23. PubMed ID: 15571873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of radon remediation programmes in the UK in the 2020s.
    Denman AR; Groves-Kirkby CJ; Crockett RGM
    J Environ Radioact; 2020 Oct; 222():106351. PubMed ID: 32892905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer risk due to residential radon exposures: estimation and prevention.
    Truta LA; Hofmann W; Cosma C
    Radiat Prot Dosimetry; 2014 Jul; 160(1-3):112-6. PubMed ID: 24751985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cost effectiveness analyses for increasing radon protection strategies in housing in Canada.
    Gaskin J; Whyte J; Zhou LG; Coyle D
    J Environ Radioact; 2021 Dec; 240():106752. PubMed ID: 34628245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-effectiveness analysis of domestic radon remediation in four primary care trusts located in Northamptonshire, UK.
    Coskeran T; Denman A; Phillips P; Tornberg R
    Health Policy; 2005 Jan; 71(1):43-56. PubMed ID: 15563992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residential radon in Canada: an uncertainty analysis of population and individual lung cancer risk.
    Brand KP; Zielinski JM; Krewski D
    Risk Anal; 2005 Apr; 25(2):253-69. PubMed ID: 15876202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.